Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of XEN901

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 19, 2018

Primary Completion Date

December 19, 2018

Study Completion Date

December 19, 2018

Conditions

Healthy Volunteers

Interventions

DRUG

XEN901

Capsule filled with XEN901

DRUG

Inert Ingredients Oral Product

Placebo capsule

Trial Locations (1)

Quotient Sciences, Ruddington

All Listed Sponsors

lead

Xenon Pharmaceuticals Inc.

INDUSTRY

NCT03467100 - Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of XEN901 | Biotech Hunter | Biotech Hunter